文献速递精神分裂症与精神病性障碍儿童青少年精神

精神疾病风险基因TCF4调控抑制性中间神经元亚型的密度与连接

Psychiatric risk gene Transcription Factor 4 (TCF4) regulates the density and connectivity of distinct inhibitory interneuron subtypes.
PubMed 文献 · Mol Psychiatry · 2023-09-28

本文综述TCF4作为碱性螺旋-环-螺旋转录因子与孤独症谱系障碍(ASD)、重度抑郁和精神分裂症的关联,并基于5种PTHS小鼠模型的bulk RNA测序数据开展细胞类型特异性表达分析(CSEA)与细胞去卷积(CD)。CSEA显示差异表达基因富集于表达小清蛋白(PV+)的中间神经元,CD预测PV+中间神经元群体减少;在Tcf4+/tr小鼠中进一步发现皮层PV+、VIP+、CST+中间神经元及纹状体ChAT+中间神经元减少,而SST+群体未受影响,并伴有兴奋/抑制输入平衡的细胞类型特异性改变。

要点

  • TCF4与ASD、重度抑郁和精神分裂症相关,其突变可致Pitt-Hopkins综合征。
  • CSEA提示差异表达基因富集于PV+中间神经元,CD预测PV+群体减少。
  • Tcf4+/tr小鼠皮层PV+、VIP+、CST+及纹状体ChAT+中间神经元减少,SST+未受累。

核心结论

  • TCF4是特定抑制性中间神经元亚型发育的关键调控因子,抑制性网络可能是PTHS病理生理的重要来源。

研究设计与样本

  • 研究对5种PTHS小鼠模型的bulk RNA测序数据进行细胞类型特异性表达分析(CSEA)与细胞去卷积(CD),并在Tcf4+/tr小鼠模型中进行免疫组化与报告小鼠分析。

主要发现

  • CSEA显示差异表达基因富集于PV+中间神经元,CD预测PV+中间神经元群体减少。
  • Tcf4+/tr小鼠皮层PV+、VIP+、CST+中间神经元及纹状体ChAT+中间神经元减少,SST+中间神经元群体未受累。
  • 特定中间神经元群体减少导致皮层内PV+、VIP+中间神经元及兴奋性锥体神经元上兴奋性与抑制性输入平衡出现细胞类型特异性改变。

临床怎么用

  • 本研究为机制性动物研究,尚未提供可直接用于精神科临床诊疗的指标或推荐。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transcription factor 4 (TCF4) is a basic helix-loop-helix transcription factor that is implicated in a variety of psychiatric disorders including autism spectrum disorder (ASD), major depression, and schizophrenia. Autosomal dominant mutations in TCF4 are causal for a specific ASD called Pitt-Hopkins Syndrome (PTHS). However, our understanding of etiological and pathophysiological mechanisms downstream of TCF4 mutations is incomplete. Single cell sequencing indicates TCF4 is highly expressed in GABAergic interneurons (INs). Here, we performed cell-type specific expression analysis (CSEA) and cellular deconvolution (CD) on bulk RNA sequencing data from 5 different PTHS mouse models. Using CSEA we observed differentially expressed genes (DEGs) were enriched in parvalbumin expressing (PV+) INs and CD predicted a reduction in the PV+ INs population. Therefore, we investigated the role of TCF4 in regulating the development and function of INs in the Tcf4+/tr mouse model of PTHS. In Tcf4+/tr mice, immunohistochemical (IHC) analysis of subtype-specific IN markers and reporter mice identified reductions in PV+, vasoactive intestinal peptide (VIP+), and cortistatin (CST+) expressing INs in the cortex and cholinergic (ChAT+) INs in the striatum, with the somatostatin (SST+) IN population being spared. The reduction of these specific IN populations led to cell-type specific alterations in the balance of excitatory and inhibitory inputs onto PV+ and VIP+ INs and excitatory pyramidal neurons within the cortex. These data indicate TCF4 is a critical regulator of the development of specific subsets of INs and highlight the inhibitory network as an important source of pathophysiology in PTHS.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chen HY, Phan BN, Shim G, et al. Psychiatric risk gene Transcription Factor 4 (TCF4) regulates the density and connectivity of distinct inhibitory interneuron subtypes. Mol Psychiatry. 2023. PMID: 37770578. doi:10.1038/s41380-023-02248-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。